Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DexTR for Relapsed or Refractory Multiple Myeloma
NCT00538824Phase 2Terminated
- Sponsor
- Weill Cornell Medicine
- Start
- Dec 2007
- Primary completion
- Sep 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide, thalidomide, dexamethasone in multiple myeloma (MM), sponsored by Weill Cornell Medicine. Started Dec 2007; status: terminated.
02
Drugs
lenalidomidethalidomidedexamethasone
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00538824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00538824.